Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.

[1]  M. Siimes,et al.  Bleeding and use of blood products after heart operations in infants. , 1995, The Journal of thoracic and cardiovascular surgery.

[2]  G. Hempelmann,et al.  Thrombomodulin in pediatric cardiac surgery. , 1994, The Annals of thoracic surgery.

[3]  C. Greenberg,et al.  Characterization of Prothrombin Activation during Cardiac Surgery by Hemostatic Molecular Markers , 1994, Anesthesiology.

[4]  S. Nicolson,et al.  Inhibition and restoration of hemostasis in the young cardiac surgical patient , 1993, Cardiology in the Young.

[5]  M. Andrew,et al.  Venous thromboembolic complications in children. , 1993, The Journal of pediatrics.

[6]  B. Pasche,et al.  The platelet function defect of cardiopulmonary bypass. , 1993, Blood.

[7]  R. Bartlett,et al.  Blood activation during neonatal extracorporeal life support , 1993 .

[8]  P. Hickey,et al.  Coagulation defects in neonates during cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[9]  C. Lacombe,et al.  Desmopressin Has No Beneficial Effect on Excessive Postoperative Bleeding or Blood Product Requirements Associated with Cardiopulmonary Bypass , 1992, Thrombosis and Haemostasis.

[10]  W. Williams,et al.  Abnormalities in von Willebrand factor and antithrombin III after cardiopulmonary bypass operations for congenital heart disease. , 1992, The Journal of thoracic and cardiovascular surgery.

[11]  R. Marlar,et al.  Severe neonatal protein C deficiency: prevalence and thrombotic risk. , 1991, The Journal of pediatrics.

[12]  D. Notterman.  Inotropic agents. Catecholamines, digoxin, amrinone. , 1991, Critical care clinics.

[13]  S. Nicolson,et al.  Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children , 1991 .

[14]  L. Harker,et al.  Bleeding complications associated with cardiopulmonary bypass. , 1990, Blood.

[15]  Boscoe M. Paes,et al.  Development of the Hemostatic System in the Neonate and Young Infant , 1990, The American journal of pediatric hematology/oncology.

[16]  J. Levy,et al.  Amrinone: pharmacokinetics and pharmacodynamics. , 1989, Journal of cardiothoracic anesthesia.

[17]  M. Manco‐Johnson.  Neonatal antithrombin III deficiency. , 1989, The American journal of medicine.

[18]  B. Risberg,et al.  Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. , 1988, Thrombosis research.

[19]  R. Montgomery,et al.  Loss of the largest von Willebrand factor multimers from the plasma of patients with congenital cardiac defects. , 1986, Blood.

[20]  F. Loop,et al.  Determinants of blood utilization during myocardial revascularization. , 1985, The Annals of thoracic surgery.

[21]  R. Wilson,et al.  Hemostasis Changes During Cardiopulmonary Bypass Surgery , 1985, Seminars in thrombosis and hemostasis.

[22]  R. Moore,et al.  Clinically silent venous thrombosis following internal and external jugular central venous cannulation in pediatric cardiac patients. , 1985, Anesthesiology.

[23]  B. Wiman,et al.  Plasma fibrinolytic activity in patients undergoing major abdominal surgery. , 1985, Acta chirurgica Scandinavica.

[24]  C. Kluft,et al.  Enhanced fibrinolytic activity during cardiopulmonary bypass in open‐heart surgery in man is caused by extrinsic (tissue‐type) plasminogen activator , 1984, European journal of clinical investigation.

[25]  B. Koops,et al.  Role of coagulopathy in newborn intracranial hemorrhage. , 1984, Pediatrics.

[26]  E. Hessel,et al.  Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: acquired transient platelet dysfunction associated with selective alpha-granule release. , 1980, Blood.

[27]  W Van Beaumont,et al.  Evaluation of hemoconcentration from hematocrit measurements. , 1972 .